[b]ACDU NEWZZZ>> FREE PRESCRIPTION DRUG DISCOUNT CARD!!![/b]
AccreditedRX.com Provides Solution to Enable Consumers to Reduce Prescription Drug Costs Without Changing Pharmacies
2012-11-30 01:31 ET - News Release
DOYLESTOWN, PA -- (Marketwire) -- 11/30/12
AccreditedRX.com formulated a solution to expensive consumer drug prescriptions. Now consumers may purchase prescription drugs from most chain drugstores at negotiated bulk prices as if they were members of a plan. By visiting AccreditedRX.com, consumers print out a coupon usable at most major pharmacies to obtain their prescriptions at discounted prices. There is no cost to the consumer.
The free prescription discount coupon can be used over and over again and does not expire. Discounts on prescription drugs will range from 10% to 85% of the retail price. Consumers with insurance can ask the pharmacist to determine if their copay is higher than the cost of the prescription with our discount card.
For consumers without the ability to log on our website, they can obtain the discounts by providing the pharmacist with the AccreditedRX.com codes and asking the pharmacy to enter the discount. The consumer should advise the pharmacist of the discount codes as follows:
RxBIN: 610268
RxPCN: PHXD
RxGRP: ACRX30
Member ID: The consumer's phone number
These contract codes are accepted at most pharmacies including the major chains such as Walgreens, Walmart, Discount Drug Mart, Target Pharmacy, K-Mart, Fred Meyer Pharmacy, Sav-More Drugs, Rite-Aid and most others. The discounts also apply to prescriptions for pet medicine as well.
Over the next two weeks, AccreditedRx.com will begin an affiliate program where sales persons, website owners, and professionals can distribute discount prescription cards to their customers and receive an incentive payment.
ABOUT AccreditedRX.com
AccreditedRX.com is a venture between R.S.S. Marketing and Accredited Business Consolidators Corp. (OTCQB: ACDU). There is no cost to the consumer, fees are paid by the drug manufacturers. AccreditedRX.com allows consumers to purchase prescription drugs from most pharmacies at negotiated discount prices. ACDU, a partner in the venture, trades on the OTCQB over the counter stock market. ACDU's authorized common shares are 450,000,000. 436,399,566 shares are outstanding of which 70,546,600 are restricted.
This is not an offer to sell securities. Statements made are forward-looking subject to risks and uncertainties. Statements included are made as of the date hereof, and the company undertakes no obligation to update such statements to reflect subsequent events or circumstances. Actual results could differ materially from anticipated results.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2168341
Add to DiggBookmark with del.icio.usAdd to Newsvine
Contact:
Accredited Business Consolidators Corp.
1-267-864-7737
1-267-371-5168 Facsimile
accreditedrx@accreditedbiz.com
www.accreditedrx.com
ACDU NEWZZZ FREE PRESCRIPTION DRUG DISCOUNT CARD!!!
Top 10 Most Recent News Articles
Digital Health Excellence: 14 Systems Earn Top Honors
The pace at which healthcare is embracing digital transformation makes one's head spin these days. Fourteen organizations just hit the jackpot of sorts—the 2026 CHIME Digital Health Most Wired survey awarded them the highest honor, Level 10. This ain't just some participation trophy; it's the real deal, putting a spotlight on organizations that aren't merely dabbling in...
Continue Reading
Dehua County Revamps Ceramic Heritage for Global Stage
Dehua's Ceramic Legacy Hits the Reset Button Alright, picture this: Dehua County in southeast China's Fujian Province has spent thirty years turning its age-old ceramic craft into a heavyweight industry. Now, it's giving that legacy a 21st-century makeover, aligning it with fashion, branding, and the global scene. This isn't just for kicks—it's a serious push fueled by...
Continue Reading
NJ Roads Spark Emmy Nod: A Public Affairs Win
Our Infrastructure Gets Its Due Sometimes, the real unsung heroes aren’t the ones under bright lights but those toiling under the sun. “Our Infrastructure Matters,” a TV and web program taking a hard-nosed look at what's keeping our roads from crumbling under the weight of millions, just landed its first-ever New York Emmy nomination. Yep, you heard it right. No,...
Continue Reading
Sunrate and TourMind Partner to Boost Travel Payments
Travel Sector Eyes Major Payment Makeover Sunrate and TourMind are shaking hands in a big way, capitalizing on the blurring lines between digital connectivity and global travel demands. Their union is the latest bid to tackle financial snags and streamline operations in this ever-evolving market. I mean, who isn't fed up with clunky payment systems when jet-setting across...
Continue Reading
SAGA Metals Strikes Potential with Wolverine Drilling Program
Drilling for Treasure in Labrador's Rich Earth Hey, ever felt that gritty thrill in your bones? That's what I imagine SAGA Metals must be feeling right now. When you're out there punching holes into Mother Earth hoping to hit pay dirt, and every single one of those holes hits something juicy—trust me, that's like hitting the jackpot before even knowing the lottery...
Continue Reading
WF Holding Cancels Additional Purchase Rights in Deal
WF Holding Calls Off Extra Purchase Rights Well, someone's decided to hit the brakes over at WF Holding Limited (NASDAQ:WFF). They're pulling the plug on an extra purchase gravy train they’d previously left open for investors. Straight from Kuala Lumpur, WF Holding's been in the fiberglass plastic game for over three decades, pushing out a product line that's almost as...
Continue Reading
NEXT Properties' Exchange Offer Sees Strong Participation
NEXT Properties Makes Bold Moves with Exchange Offers NEXT Properties has pulled the trigger on a massive swap of its notes, and it's a tale investors should tune into. They're swapping out their old notes like a veteran trader ditching penny stocks for blue chips. It’s an intriguing maneuver—risk-laden yet foreboding to anyone who knows the game. Breaking Down the...
Continue Reading
Gildan Faces Heat: Channel Stuffing Allegations Arise
Gildan's Stocks Take a Dive Amid Allegations Just when you thought the market swings were calming down, Gildan Activewear Inc. (NYSE: GIL) lands in hot water, sending investors scrambling. The spotlight's on them, thanks to some eye-catching accusations from Jehoshaphat Research. The word on the street is Gildan's been engaging in some questionable financial gymnastics...
Continue Reading
DaVita's Stand on HHS Kidney Plan: Innovation at Core
DaVita Stands Firm on Kidney Care Innovation The healthcare landscape's shifting undercurrent, folks, and kidney care has landed smack in the spotlight with the U.S. Department of Health and Human Services (HHS) putting forth its Kidney Care National Plan. Now, this isn't some bureaucratic mumbo-jumbo—this plan's setting the tone for kidney disease treatment across...
Continue Reading
Ellevio Bolsters Stockholm Grid with SEK 1B NIB Loan
In a move that packs plenty of juice for Stockholm's energy needs, Ellevio has shaken hands with the Nordic Investment Bank (NIB) in a hefty SEK 1 billion loan agreement. This isn’t just some pocket change—this financing is a ticket to revamping and beefing up the Beckomberga substation, a project hailed for fortifying the regional electricity grid in the Swedish...
Continue ReadingTop 5 Most Recently Viewed Articles
Navigating the Financial Future: Insights for 2025 Retirement Planning
Current Challenges for Retirement Savers and Business Owners As we step into 2025, American workers and small business owners face significant uncertainty. Such concerns arise from ongoing inflationary pressures and high interest rates that linger in the economy. With a new presidential administration in place, changes in policy also play a pivotal role in shaping the...
Continue Reading
Innovative Insights into Premature Ejaculation Treatment Growth
The Transformation of the Premature Ejaculation Treatment Market The global market for premature ejaculation treatment is undergoing a significant transformation, projected to experience growth of USD 1.53 billion between 2025 and 2029. This trend highlights the robust expansion that comes with the growing awareness and demand for effective treatment options. Various...
Continue Reading
Peachtree Group Achieves Milestone with $1 Billion CPACE Financing
Peachtree Group Reaches a Significant Financial Milestone Peachtree Group has made waves in the financial landscape with a remarkable achievement, crossing the $1 billion threshold in Commercial Property Assessed Clean Energy (CPACE) financing. This impressive feat places Peachtree among a select group of industry leaders, showcasing its commitment and innovative approach...
Continue Reading
Leads Biolabs Continues Innovative Trials for Advanced Melanoma
Breakthrough in Melanoma Treatment: First Patient Dosed Leads Biolabs Co., Ltd. is excited to announce a significant milestone in the fight against advanced melanoma, as the first patient has been successfully dosed in a pivotal Phase 1b/II clinical trial evaluating Opamtistomig. This new treatment has shown a lot of promise as a PD-L1/4-1BB bispecific antibody aimed at...
Continue Reading
Investigating Financial Issues at Simulations Plus: What Investors Need to Know
Understanding the Investigation of Simulations Plus In light of recent developments, an investigation is underway regarding the financial practices of Simulations Plus, Inc. (NASDAQ: SLP). Concerns have emerged related to potential violations of federal securities laws that may have impacted investors significantly. This investigation, initiated by legal representatives,...
Continue Reading